Donate

Breast Cancer
Screening & Diagnosis

Screen recommendations:

The US Preventive Services Task Force is an organization made up of doctors and disease experts who look at research on the best way to prevent diseases and make recommendations on how doctors can help patients avoid diseases or find them early.

The Task Force recommends that women who are 40 to 74 years old and are at average risk for breast cancer get a mammogram every 2 years. Women should weigh the benefits and risks of screening tests (see below).

Some warning signs of breast cancer are:

Keep in mind that these symptoms can happen with other conditions that are not cancer. If you have any signs or symptoms, be sure to see your doctor right away.

Breast cancer is the second leading cause of cancer death in U.S. women, behind lung cancer. The chance that a woman will die from breast cancer is 1 in 39, or about 2.5%. In 2024, an estimated 42,250 women will die from breast cancer in the U.S.

Breast cancer death rates have slowly decreased since 1989, for an overall decline of 43% through 2020. This is in part due to better screening and early detection efforts, increased awareness, and continually improving treatment options. Women who receive regular screenings for breast cancer have a 26% lower breast cancer death rate than women who do not receive screenings.

Breast cancer in men statistics

All people are born with some breast cells and tissue, including men. Although rare, men get breast cancer too.
In 2024, an estimated 2,800 men will be diagnosed with invasive breast cancer in the United States.

The lifetime risk of a U.S. man developing breast cancer is about 1 in 833.

Black men with breast cancer tend to have a worse prognosis, or outlook, than white men with breast cancer.

Breast cancer under 40 is called Adolescents and Young Adults (AYA)

Breast cancers in women under 40 are more likely to have features that can contribute to poorer prognoses and outcomes: larger tumor size, advanced tumor stage, negative hormone receptor status, and an overexpression of the HER2 protein.

1. Young women are more likely to have aggressive forms of the disease.

Breast cancers in women under 40 are more likely to have features that can contribute to poorer prognoses and outcomes: larger tumor size, advanced tumor stage, negative hormone receptor status, and an overexpression of the HER2 protein. Triple-negative breast cancer (TNBC)—a particularly aggressive subtype without many targeted treatment options, though that is changing—is also more common in younger women. In addition, rates of metastatic breast cancer in women under 40 have risen 3.5 percent each year between 2004 and 2017. Younger women are also more likely to experience a recurrence at five and 10 years after therapy compared to older women.

2. Racial disparities are pervasive among young Black women.

Black women are nearly twice as likely to be diagnosed with TNBC compared to white women aged 20 to 44. Also, studies show that Black women aged 20 to 39 are more likely to develop breast cancer of any subtype compared to younger women of other racial and ethnic groups and one-and-a-half times more likely to develop breast cancer compared to white women between the ages of 20 and 29.

3. Younger patients are more likely to have genetic risk factors for breast cancer.

Inherited mutations in BRCA1 or BRCA2 genes, which increase breast cancer risk, are more commonly seen in young women. While about six percent of all women with breast cancer are carriers for BRCA mutations, the number is closer to 12 percent in patients under 45 with breast cancer. Women of Ashkenazi Jewish descent are particularly vulnerable because BRCA mutations are more prevalent in this group.

Has one or more family members who:

Find the support you need

icon white helpline

Support line

Speak with a survivor, caregiver, or peer who has faced the same challenges you’re dealing with.

icon patient navigation white

Patient Navigation

Receive personalized guidance and support from our patient navigators to help you through every stage of your breast cancer treatment.

icon white support group

Support Groups

Connect with others who have been diagnosed with breast cancer and find strength in shared experiences.

icon white clinical trials

Clinical Trials

Know your options for treatments in development.

icon white live webinars

Live Webinars

Gain insights and expert advice from our live webinars designed to empower and inform you every step of the way.

icon white caregivers

Caregivers

Navigate your way as a cancer caregiver.

icon webinars on demand white

Video Library

Watch our videos for expert guidance and insights on managing the challenges of breast cancer.